Fetal Hematopoiesis

Overview

Process forming cellular elements of blood.
Hemangioblast believed origin stem cell for endothelial and hematopoietic cells.
Multipotent cells capable of self-renewal and clonal maturation.
Long-term repopulating hematopoietic stem cells (LTR-HSCs) differentiate into multipotent progenitors (MPPs).
MPPs yield common lymphoid progenitors (CLPs) and common myeloid progenitors (CMPs).
CMPs differentiate into all non-lymphoid blood lineages.
Regulation dependent on specific transcription factors and local hematopoietic growth factors.

Stage	Gestational Timeline	Primary Anatomic Site	Predominant Cell Lineages Produced
Mesoblastic	10–14 days to 10–12 weeks	Yolk sac (extraembryonic)	Erythrocytes, megakaryocytes, macrophages.
Hepatic	6–8 weeks to 2nd trimester	Fetal liver, placenta	Erythrocytes, megakaryocytes, leukocytes.
Myeloid	2nd trimester through term	Bone marrow	Erythrocytes, megakaryocytes, leukocytes.

Fetal erythrocytes significantly larger than adult erythrocytes.
Mean corpuscular volume (MCV) reaches 135 fL at 22–23 weeks gestation; falls linearly.
Mean corpuscular hemoglobin (MCH) high at 22–23 weeks; falls linearly with advancing gestation.
Mean corpuscular hemoglobin concentration (MCHC) constant throughout gestation (34 ±1 g/dL).
Hematocrit and blood hemoglobin concentration gradually increase with advancing gestation.

Erythropoietin (EPO) essential for erythroblast survival and proliferation.
Maternal EPO does not cross placenta; entirely fetal regulated.
Fetal liver (monocytes/macrophages) produces EPO during 1st and 2nd trimesters.
Anatomic site of EPO production shifts to kidney postnatally.
Oxygen-sensing mechanism regulated by Hypoxia-Inducible Factor (HIF) family proteins (HIF-1 $α$ , HIF-2 $α$ ).

Globin chain expression strictly developmental stage-specific.
First hemoglobin switch: ~6 weeks gestation (embryonic to fetal globin).
Second hemoglobin switch: mid-gestation (fetal to adult globin).
BCL11A transcription factor critical regulator; represses $γ$ -globin expression (silencing fetal hemoglobin).

Hemoglobin Type	Structure	Developmental Expression Pattern
Gower-1 (Embryonic)	$ζ_{2} ϵ_{2}$	Predominates <6 weeks; undetectable by 3 months.
Gower-2 (Embryonic)	$α_{2} ϵ_{2}$	Predominates <6 weeks; undetectable by 3 months.
Portland (Embryonic)	$ζ_{2} γ_{2}$	Predominates <6 weeks; undetectable by 3 months.
HbF (Fetal)	$α_{2} γ_{2}$	Major fetal Hb; declines rapidly postnatally.
HbA (Adult)	$α_{2} β_{2}$	First appears 1 month gestation; 30% at term.
HbA2 (Adult Minor)	$α_{2} δ_{2}$	<1% at birth; reaches adult level (2.0-3.4%) by 12 months.

Developmentally unique pattern: rapid proliferation followed by full cytoplasmic maturation without polyploidization.
Fetal megakaryocytes smaller with lower ploidy (primarily 2N and 4N) compared to adult modal ploidy (16N).
Fetal megakaryocytes produce fewer individual platelets but maintain higher overall proliferative potential.
Mean platelet volume remains constant (8 ±1 fL) during gestation.
Blood platelet concentration increases gradually between 22 and 40 weeks.

Neutrophils initially observed ~5 weeks gestation around fetal aorta.
Macrophages appear before neutrophils in yolk sac, liver, lung, and brain.
Fetal bone marrow cavity develops ~8th week; neutrophils appear ~10.5 weeks.
Neutrophils become most common granulocytic marrow cell from 14 weeks through term.
Circulating neutrophils remain scarce (0-500/mm³) until 3rd trimester.

Granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) expressed in bone at 6 weeks; liver at 8 weeks.
Fetal blood contains abundant neutrophil progenitor clones.
Low mid-trimester circulating neutrophils attributed to low G-CSF production by fetal monocytes.
Neonatal neutrophil G-CSF receptors equal in number and affinity to adult receptors.